StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 15/3036% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals Europe — Net product revenues by Quarter

Europe — Net product revenues ($M) ($M)

QuarterlyAnnual

Vertex Pharmaceuticals Europe — Net product revenues: $978M in Q2 2026, up 7.3% from a year earlier. That is the highest of the 38 quarters on record here.

Latest, Q2 2026
978
Period ended Jun 30, 2026
Change on a year earlier
+7.3%
911 in Q2 2025
History
38 quarters
Since Q1 2017
Sources
33
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-04) ↗

Reported in Form 10-Q / 10-K Segment & Geographic Information Note.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedEurope — Net product revenues ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026978+7.3%Form 10-Q (filed 2026-08-04) ↗
Q1 2026Mar 31, 2026950+14.9%Form 10-Q (filed 2026-05-05) ↗
Q4 2025Dec 31, 2025886+6.5%Form 10-K (filed 2026-02-13) ↗
Q3 2025Sep 30, 2025837-1.3%Form 10-Q (filed 2025-11-04) ↗
Q2 2025Jun 30, 2025911+12.9%Form 10-Q (filed 2026-08-04) ↗
Q1 2025Mar 31, 2025827-14.6%Form 10-Q (filed 2026-05-05) ↗
Q4 2024Dec 31, 2024832+13.2%Form 10-K (filed 2026-02-13) ↗
Q3 2024Sep 30, 2024848+10.6%Form 10-Q (filed 2025-11-04) ↗
Q2 2024Jun 30, 2024807+0.8%Form 10-Q (filed 2025-08-05) ↗
Q1 2024Mar 31, 2024967+19.8%Form 10-Q (filed 2025-05-06) ↗
Q4 2023Dec 31, 2023735+7.0%Form 10-K (filed 2026-02-13) ↗
Q3 2023Sep 30, 2023767+4.9%Form 10-Q (filed 2024-11-05) ↗
Q2 2023Jun 30, 2023800+22.0%Form 10-Q (filed 2024-08-02) ↗
Q1 2023Mar 31, 2023807+27.7%Form 10-Q (filed 2024-05-07) ↗
Q4 2022Dec 31, 2022687+16.4%Form 10-K (filed 2025-02-13) ↗
Q3 2022Sep 30, 2022731+40.8%Form 10-Q (filed 2023-11-07) ↗

Cite this data

StockData. (2026). Vertex Pharmaceuticals Europe — Net product revenues ($M), quarterly Q1 2017–Q2 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/rev-geo-europe

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.